Department of Defense$21.1K obligationsEnds Jun 3, 2026
Federal contract award
W91YTZ22P0033
KACC FORT MEADE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRCO EAST |
| NAICS | 325120 — Industrial Gas Manufacturing |
| PSC | 6830 — Gases: Compressed and Liquefied |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $186.3K |
| Current contract value | $186.3K |
| Potential contract value / ceiling | $235.1K |
| Start date | Mar 21, 2022 |
| Current end date | Mar 22, 2026 |
| Potential end date | Mar 22, 2027 |
| Latest award activity | Jun 11, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 17 of 17 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 11, 2026 | P00016 | $0 | MEDICAL GASES: |
| Jun 4, 2025 | P00014 | $0 | PROVIDE MEDICAL GASSES: KIMBROUGH AMBULATORY CARE CENTER, DUNHAM HEALTH CLINIC, ANDREW RADAR HEALTH CLINIC, CARLISLE BARRACKS, FILLMORE HEALTH CLINIC, KIRK HEALTH CLINIC, FORENSIC TOXICOLOGY DRUG TESTING LABORATORY (FTDTL) AND BARQUIST HEALTH CLINIC. |
| May 13, 2025 | P00013 | $0 | PROVIDE MEDICAL GASSES: KIMBROUGH AMBULATORY CARE CENTER, DUNHAM HEALTH CLINIC, ANDREW RADAR HEALTH CLINIC, CARLISLE BARRACKS, FILLMORE HEALTH CLINIC, KIRK HEALTH CLINIC, FORENSIC TOXICOLOGY DRUG TESTING LABORATORY (FTDTL) AND BARQUIST HEALTH CLINIC. |
| Mar 21, 2025 | P00015 | $46.3K | PROVIDE MEDICAL GASSES: KIMBROUGH AMBULATORY CARE CENTER, DUNHAM HEALTH CLINIC, ANDREW RADAR HEALTH CLINIC, CARLISLE BARRACKS, FILLMORE HEALTH CLINIC, KIRK HEALTH CLINIC, FORENSIC TOXICOLOGY DRUG TESTING LABORATORY (FTDTL) AND BARQUIST HEALTH CLINIC. |
| Jan 31, 2025 | P00012 | $5.2K | DCS BMOD FY25 - AIRGAS ADDITIONAL FUNDING KACC |
| Aug 8, 2024 | P00011 | $45.5K | FUNDING MODIFICATION OY2 |
| Mar 22, 2024 | P00010 | $150 | KACC FORT MEADE |
| Jan 9, 2024 | P00009 | $0 | KACC FORT MEADE |
| Feb 7, 2023 | P00008 | $300 | ADD ADDITIONAL FUNDS TO CLIN 0002 - W91YTZ22P0033 |
| Jan 27, 2023 | P00007 | $0 | KACC FORT MEADE |
| Jan 19, 2023 | P00006 | $45.5K | MOD - FUNDING OY1 |
| Dec 22, 2022 | P00005 | $0 | ADM MOD - CORRECT POP WORDING |
| Dec 21, 2022 | P00004 | $0 | MODIFICATION - OPTION EXERCISE OY 1 |
| Jul 1, 2022 | P00003 | $0 | KACC FORT MEADE |
| Mar 31, 2022 | P00002 | $0 | KACC FORT MEADE |
| Mar 23, 2022 | P00001 | $0 | KACC FORT MEADE |
| Mar 21, 2022 | 0 | $43.4K | KACC FORT MEADE |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-03-22 (148 days from calculation)
- +35 points
- 6 historical awards in this buyer and category group
- +15 points
- 17 recorded award transactions
- +10 points
- Latest award action: 2026-06-11
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.